SCHEMBL19906342

SCHEMBL19906342

CCCN[C@@H](C)C(=O)OCC(C)(C)OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN1A P35498 3/20 0.35
SCN2A Q99250 3/20 0.35
SCN3A Q9NY46 3/20 0.35
CYP3A4 P08684 2/20 0.35
HTR1A P08908 2/20 0.35
CYP1A2 P05177 1/20 0.35
PGR P06401 1/20 0.34
LMNA P02545 2/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
METAP2 P50579 1/20 0.31
METAP1 P53582 1/20 0.31
TDP1 Q9NUW8 3/20 0.31
TSHR P16473 3/20 0.31
CYP2D6 P10635 1/20 0.31
SLC6A3 Q01959 1/20 0.31
SCN5A Q14524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19906319 0.79 GRIN2D (0.32) METAP2METAP1TDP1TSHRALDH1A1
SCHEMBL15499370 0.79 GRIN2D (0.32) METAP2METAP1TDP1TSHRALDH1A1
SCHEMBL18430098 0.79 CA14 (0.35) CA1CA2METAP2METAP1TDP1
SCHEMBL23327618 0.78 CA14 (0.45) SCN1ASCN2ASCN3ACYP3A4HTR1A
SCHEMBL17929538 0.78 CA14 (0.45) SCN1ASCN2ASCN3ACYP3A4HTR1A
SCHEMBL24149385 0.77 GRIN2D (0.37) CYP3A4CYP1A2METAP2METAP1CYP2D6
SCHEMBL11183460 0.76 SCN1A (0.44) SCN1ASCN2ASCN3ACYP3A4HTR1A
SCHEMBL7904488 0.76 SCN1A (0.44) SCN1ASCN2ASCN3ACYP3A4HTR1A
SCHEMBL21385629 0.75 ACHE (0.38) CA1CA2ZDHHC7
SCHEMBL28986517 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2890704-B1 2'-ETHYNYL NUCLEOSIDE DERIVATIVES FOR TREATMENT OF VIRAL INFECTIONS NOVARTIS AG (CH) 2018-02-28 EP disclosed